Treatment of metastatic castration-resistant prostate cancer patients with abiraterone acetate and prednisone and corresponding survival prognostic factors

  1. JIMENEZ ROMERO, M.E.
  2. GALLEGO, M.C.
  3. NAVARRO SERRATO, J.C.
  4. SANCHEZ HURTADO, M.A.
  5. SANTOTORIBIO, J.D.
Revue:
Anticancer Research

ISSN: 1791-7530 0250-7005

Année de publication: 2021

Volumen: 41

Número: 8

Pages: 3955-3968

Type: Article

DOI: 10.21873/ANTICANRES.15192 GOOGLE SCHOLAR lock_openAccès ouvert editor